ID   CD11A_HUMAN             Reviewed;         780 AA.
AC   Q9UQ88; O95227; O95228; O96012; Q12821; Q12853; Q12854; Q2TAJ0;
AC   Q5QPR0; Q5QPR1; Q5QPR2; Q9UBC4; Q9UBI3; Q9UEI1; Q9UEI2; Q9UP53;
AC   Q9UP54; Q9UP55; Q9UP56; Q9UQ86; Q9UQ87; Q9UQ89;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 3.
DT   05-OCT-2010, entry version 97.
DE   RecName: Full=Cell division protein kinase 11A;
DE            EC=2.7.11.22;
DE   AltName: Full=Cell division cycle 2-like protein kinase 2;
DE   AltName: Full=Galactosyltransferase-associated protein kinase p58/GTA;
DE   AltName: Full=PITSLRE serine/threonine-protein kinase CDC2L2;
GN   Name=CDK11A; Synonyms=CDC2L2, CDC2L3, PITSLREB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS SV1; SV2 AND 4), TISSUE
RP   SPECIFICITY, SUBCELLULAR LOCATION, AND VARIANT SER-399.
RC   TISSUE=Cervix carcinoma;
RX   MEDLINE=94253170; PubMed=8195233;
RA   Xiang J., Lahti J.M., Grenet J.A., Easton J.B., Kidd V.J.;
RT   "Molecular cloning and expression of alternatively spliced PITSLRE
RT   protein kinase isoforms.";
RL   J. Biol. Chem. 269:15786-15794(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS SV1; SV2; SV3; SV6; SV7; SV12 AND
RP   SV13), TISSUE SPECIFICITY, AND VARIANT TRP-93.
RC   TISSUE=Cervix carcinoma;
RX   MEDLINE=98424414; PubMed=9750192;
RA   Gururajan R., Lahti J.M., Grenet J.A., Easton J., Gruber I.,
RA   Ambros P.F., Kidd V.J.;
RT   "Duplication of a genomic region containing the Cdc2L1-2 and MMP21-22
RT   genes on human chromosome 1p36.3 and their linkage to D1Z2.";
RL   Genome Res. 8:929-939(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT TRP-93.
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SV7).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CCNL1 AND SFRS7.
RX   MEDLINE=22499644; PubMed=12501247; DOI=10.1074/jbc.M210057200;
RA   Hu D., Mayeda A., Trembley J.H., Lahti J.M., Kidd V.J.;
RT   "CDK11 complexes promote pre-mRNA splicing.";
RL   J. Biol. Chem. 278:8623-8629(2003).
RN   [6]
RP   ALTERNATIVE INITIATION (ISOFORM 4), AND INDUCTION.
RX   MEDLINE=20337944; PubMed=10882096; DOI=10.1016/S1097-2765(00)80239-7;
RA   Cornelis S., Bruynooghe Y., Denecker G., Van Huffel S., Tinton S.,
RA   Beyaert R.;
RT   "Identification and characterization of a novel cell cycle-regulated
RT   internal ribosome entry site.";
RL   Mol. Cell 5:597-605(2000).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH PAK1.
RX   MEDLINE=22651041; PubMed=12624090; DOI=10.1074/jbc.M300818200;
RA   Chen S., Yin X., Zhu X., Yan J., Ji S., Chen C., Cai M., Zhang S.,
RA   Zong H., Hu Y., Yuan Z., Shen Z., Gu J.;
RT   "The C-terminal kinase domain of the p34cdc2-related PITSLRE protein
RT   kinase (p110C) associates with p21-activated kinase 1 and inhibits its
RT   activity during anoikis.";
RL   J. Biol. Chem. 278:20029-20036(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-222; SER-271; THR-736
RP   AND SER-737, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271; THR-580; THR-736
RP   AND SER-737, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-271; SER-574;
RP   THR-580; THR-736; SER-737 AND THR-758, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-572; SER-574 AND
RP   THR-580, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-580, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
CC   -!- FUNCTION: Appears to play multiple roles in cell cycle
CC       progression, cytokinesis and apoptosis. The p110 isoforms have
CC       been suggested to be involved in pre-mRNA splicing, potentially by
CC       phosphorylating the splicing protein SFRS7. The p58 isoform may
CC       act as a negative regulator of normal cell cycle progression.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Phosphorylation at Thr-433 or Tyr-434
CC       inactivates the enzyme, while phosphorylation at Thr-580 activates
CC       it (By similarity).
CC   -!- SUBUNIT: The cleaved p110 isoform, p110C, binds to the
CC       serine/threonine kinase PAK1. The p58 isoform but not the p110
CC       isoform or p110C interacts with CCND3. The p110 isoforms are found
CC       in large molecular weight complexes containing CCNL1 and SFRS7.
CC   -!- INTERACTION:
CC       Q15477:SKIV2L; NbExp=1; IntAct=EBI-373024, EBI-373226;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=8;
CC         Comment=Additional isoforms seem to exist;
CC       Name=SV6; Synonyms=p110;
CC         IsoId=Q9UQ88-1; Sequence=Displayed;
CC       Name=SV1; Synonyms=Pbeta21, Beta 2-1;
CC         IsoId=Q9UQ88-2; Sequence=VSP_008286, VSP_008288;
CC         Note=Ref.1 (AAA19594) sequence is in conflict in positions:
CC         109:C->R, 112:H->R;
CC       Name=SV2; Synonyms=Pbeta22;
CC         IsoId=Q9UQ88-3; Sequence=VSP_008287, VSP_008288;
CC         Note=Ref.1 (AAA19595) sequence is in conflict in position:
CC         158:F->V;
CC       Name=SV3;
CC         IsoId=Q9UQ88-4; Sequence=VSP_008288;
CC       Name=SV7; Synonyms=SV8;
CC         IsoId=Q9UQ88-5; Sequence=VSP_008283, VSP_008289;
CC       Name=SV12;
CC         IsoId=Q9UQ88-8; Sequence=VSP_008284, VSP_008292;
CC       Name=SV13;
CC         IsoId=Q9UQ88-9; Sequence=VSP_008281, VSP_008287, VSP_008288,
CC                                  VSP_008290, VSP_008291;
CC       Name=4; Synonyms=Beta 1, p58;
CC         IsoId=Q9UQ88-10; Sequence=VSP_018836;
CC         Note=Produced by alternative initiation at Met-342 of isoform
CC         SV6;
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously. Some evidence of
CC       isoform-specific tissue distribution.
CC   -!- INDUCTION: The p58 isoform is specifically induced in G2/M phase
CC       of the cell cycle.
CC   -!- PTM: During apoptosis, induced by Fas or tumor necrosis factor,
CC       specific CKD11 p110 isoforms are cleaved by caspases to produce a
CC       protein (p110C) that contains the C-terminal kinase domain of the
CC       CDK11 proteins.
CC   -!- MISCELLANEOUS: Duplicated gene. CDK11A and CDK11B encode almost
CC       identical protein kinases of 110 kDa that contain at their C-
CC       termini the open reading frame of a smaller 58 kDa isoform which
CC       is expressed following IRES-mediated alternative initiation of
CC       translation.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- CAUTION: Many references talk about 'p110 isoforms' but it is not
CC       yet known if this refers to CDK11A and/or CDK11B or one/some of
CC       the isoforms of each.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC95297.1; Type=Erroneous gene model prediction;
CC       Sequence=AAC95298.1; Type=Erroneous gene model prediction;
CC       Sequence=AAC95299.1; Type=Erroneous gene model prediction;
CC       Sequence=AAC95300.1; Type=Erroneous gene model prediction;
CC       Sequence=AAC95302.1; Type=Erroneous gene model prediction;
CC       Sequence=AAC95303.1; Type=Erroneous gene model prediction;
CC       Sequence=CAI20032.1; Type=Erroneous gene model prediction;
CC       Sequence=CAI20033.1; Type=Erroneous gene model prediction;
CC       Sequence=CAI20034.1; Type=Erroneous gene model prediction;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U04819; AAA19585.1; -; mRNA.
DR   EMBL; U07704; AAA19594.1; -; mRNA.
DR   EMBL; U07705; AAA19595.1; -; mRNA.
DR   EMBL; AF067518; AAC72083.1; -; mRNA.
DR   EMBL; AF067519; AAC72084.1; -; mRNA.
DR   EMBL; AF067520; AAC72085.1; -; mRNA.
DR   EMBL; AF067521; AAC72086.1; -; mRNA.
DR   EMBL; AF067522; AAC72087.1; -; mRNA.
DR   EMBL; AF067523; AAC72088.1; -; mRNA.
DR   EMBL; AF067524; AAC72089.1; -; mRNA.
DR   EMBL; AF067525; AAC72090.1; -; mRNA.
DR   EMBL; AF067526; AAC72091.1; -; mRNA.
DR   EMBL; AF067527; AAC72092.1; -; mRNA.
DR   EMBL; AF067528; AAC72093.1; -; mRNA.
DR   EMBL; AF067529; AAC72094.1; -; mRNA.
DR   EMBL; AF080694; AAC95297.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF080695; AAC95297.1; JOINED; Genomic_DNA.
DR   EMBL; AF105714; AAC95297.1; JOINED; Genomic_DNA.
DR   EMBL; AF080696; AAC95297.1; JOINED; Genomic_DNA.
DR   EMBL; AF080697; AAC95297.1; JOINED; Genomic_DNA.
DR   EMBL; AF092427; AAC95297.1; JOINED; Genomic_DNA.
DR   EMBL; AF092428; AAC95297.1; JOINED; Genomic_DNA.
DR   EMBL; AF080689; AAC95297.1; JOINED; Genomic_DNA.
DR   EMBL; AF080690; AAC95297.1; JOINED; Genomic_DNA.
DR   EMBL; AF080691; AAC95297.1; JOINED; Genomic_DNA.
DR   EMBL; AF080692; AAC95297.1; JOINED; Genomic_DNA.
DR   EMBL; AF080693; AAC95297.1; JOINED; Genomic_DNA.
DR   EMBL; AF080694; AAC95298.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF080695; AAC95298.1; JOINED; Genomic_DNA.
DR   EMBL; AF105714; AAC95298.1; JOINED; Genomic_DNA.
DR   EMBL; AF080696; AAC95298.1; JOINED; Genomic_DNA.
DR   EMBL; AF080697; AAC95298.1; JOINED; Genomic_DNA.
DR   EMBL; AF092427; AAC95298.1; JOINED; Genomic_DNA.
DR   EMBL; AF092428; AAC95298.1; JOINED; Genomic_DNA.
DR   EMBL; AF080689; AAC95298.1; JOINED; Genomic_DNA.
DR   EMBL; AF080690; AAC95298.1; JOINED; Genomic_DNA.
DR   EMBL; AF080691; AAC95298.1; JOINED; Genomic_DNA.
DR   EMBL; AF080692; AAC95298.1; JOINED; Genomic_DNA.
DR   EMBL; AF080693; AAC95298.1; JOINED; Genomic_DNA.
DR   EMBL; AF080694; AAC95299.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF080695; AAC95299.1; JOINED; Genomic_DNA.
DR   EMBL; AF105714; AAC95299.1; JOINED; Genomic_DNA.
DR   EMBL; AF080696; AAC95299.1; JOINED; Genomic_DNA.
DR   EMBL; AF080697; AAC95299.1; JOINED; Genomic_DNA.
DR   EMBL; AF092427; AAC95299.1; JOINED; Genomic_DNA.
DR   EMBL; AF092428; AAC95299.1; JOINED; Genomic_DNA.
DR   EMBL; AF080689; AAC95299.1; JOINED; Genomic_DNA.
DR   EMBL; AF080690; AAC95299.1; JOINED; Genomic_DNA.
DR   EMBL; AF080691; AAC95299.1; JOINED; Genomic_DNA.
DR   EMBL; AF080692; AAC95299.1; JOINED; Genomic_DNA.
DR   EMBL; AF080693; AAC95299.1; JOINED; Genomic_DNA.
DR   EMBL; AF080694; AAC95300.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF080695; AAC95300.1; JOINED; Genomic_DNA.
DR   EMBL; AF105714; AAC95300.1; JOINED; Genomic_DNA.
DR   EMBL; AF080696; AAC95300.1; JOINED; Genomic_DNA.
DR   EMBL; AF080697; AAC95300.1; JOINED; Genomic_DNA.
DR   EMBL; AF092427; AAC95300.1; JOINED; Genomic_DNA.
DR   EMBL; AF092428; AAC95300.1; JOINED; Genomic_DNA.
DR   EMBL; AF080689; AAC95300.1; JOINED; Genomic_DNA.
DR   EMBL; AF080690; AAC95300.1; JOINED; Genomic_DNA.
DR   EMBL; AF080691; AAC95300.1; JOINED; Genomic_DNA.
DR   EMBL; AF080692; AAC95300.1; JOINED; Genomic_DNA.
DR   EMBL; AF080693; AAC95300.1; JOINED; Genomic_DNA.
DR   EMBL; AF080697; AAC95302.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF080695; AAC95302.1; JOINED; Genomic_DNA.
DR   EMBL; AF105714; AAC95302.1; JOINED; Genomic_DNA.
DR   EMBL; AF080696; AAC95302.1; JOINED; Genomic_DNA.
DR   EMBL; AF080697; AAC95303.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF080695; AAC95303.1; JOINED; Genomic_DNA.
DR   EMBL; AF105714; AAC95303.1; JOINED; Genomic_DNA.
DR   EMBL; AF080696; AAC95303.1; JOINED; Genomic_DNA.
DR   EMBL; AL031282; CAI20032.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL031282; CAI20033.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL031282; CAI20034.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC110905; AAI10906.1; -; mRNA.
DR   IPI; IPI00024413; -.
DR   IPI; IPI00024414; -.
DR   IPI; IPI00070809; -.
DR   IPI; IPI00099746; -.
DR   IPI; IPI00219508; -.
DR   IPI; IPI00294006; -.
DR   IPI; IPI00334381; -.
DR   IPI; IPI00954484; -.
DR   PIR; B54024; B54024.
DR   PIR; E54024; E54024.
DR   PIR; F54024; F54024.
DR   PIR; H54024; H54024.
DR   RefSeq; NP_076916.2; -.
DR   RefSeq; NP_277071.2; -.
DR   UniGene; Hs.651228; -.
DR   UniGene; Hs.709182; -.
DR   ProteinModelPortal; Q9UQ88; -.
DR   SMR; Q9UQ88; 390-704, 426-721.
DR   IntAct; Q9UQ88; 3.
DR   STRING; Q9UQ88; -.
DR   PhosphoSite; Q9UQ88; -.
DR   Ensembl; ENST00000341028; ENSP00000344418; ENSG00000008128.
DR   Ensembl; ENST00000378633; ENSP00000367900; ENSG00000008128.
DR   GeneID; 728642; -.
DR   KEGG; hsa:728642; -.
DR   UCSC; uc009vkk.1; human.
DR   UCSC; uc009vks.1; human.
DR   CTD; 728642; -.
DR   GeneCards; GC01M001567; -.
DR   HGNC; HGNC:1730; CDK11A.
DR   HPA; CAB010467; -.
DR   HPA; HPA025061; -.
DR   MIM; 116951; gene.
DR   PharmGKB; PA26263; -.
DR   eggNOG; prNOG11249; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; Q9UQ88; -.
DR   PhylomeDB; Q9UQ88; -.
DR   BRENDA; 2.7.11.22; 247.
DR   Reactome; REACT_152; Cell Cycle, Mitotic.
DR   NextBio; 127852; -.
DR   ArrayExpress; Q9UQ88; -.
DR   Bgee; Q9UQ88; -.
DR   Genevestigator; Q9UQ88; -.
DR   GermOnline; ENSG00000008128; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004693; F:cyclin-dependent protein kinase activity; IEA:EC.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0006915; P:apoptosis; NAS:UniProtKB.
DR   GO; GO:0007067; P:mitosis; NAS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0001558; P:regulation of cell growth; IEP:UniProtKB.
DR   GO; GO:0050684; P:regulation of mRNA processing; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; NAS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative initiation; Alternative splicing; Apoptosis; ATP-binding;
KW   Cell cycle; Complete proteome; Cytoplasm; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    780       Cell division protein kinase 11A.
FT                                /FTId=PRO_0000024315.
FT   DOMAIN      424    644       Protein kinase.
FT   NP_BIND     429    437       ATP (By similarity).
FT   COMPBIAS     15    378       Glu-rich.
FT   ACT_SITE    547    547       Proton acceptor (By similarity).
FT   BINDING     452    452       ATP (By similarity).
FT   MOD_RES      47     47       Phosphoserine.
FT   MOD_RES     222    222       Phosphoserine.
FT   MOD_RES     271    271       Phosphoserine.
FT   MOD_RES     433    433       Phosphothreonine (By similarity).
FT   MOD_RES     434    434       Phosphotyrosine (By similarity).
FT   MOD_RES     572    572       Phosphotyrosine.
FT   MOD_RES     574    574       Phosphoserine.
FT   MOD_RES     580    580       Phosphothreonine.
FT   MOD_RES     736    736       Phosphothreonine.
FT   MOD_RES     737    737       Phosphoserine.
FT   MOD_RES     758    758       Phosphothreonine.
FT   VAR_SEQ       1    613       Missing (in isoform SV12).
FT                                /FTId=VSP_008284.
FT   VAR_SEQ       1    383       Missing (in isoform SV7).
FT                                /FTId=VSP_008283.
FT   VAR_SEQ       1    341       Missing (in isoform 4).
FT                                /FTId=VSP_018836.
FT   VAR_SEQ       1     57       Missing (in isoform SV13).
FT                                /FTId=VSP_008281.
FT   VAR_SEQ     109    109       W -> CRHHSHSAEGG (in isoform SV1).
FT                                /FTId=VSP_008286.
FT   VAR_SEQ     153    153       R -> RGNDGFCLFR (in isoform SV2 and
FT                                isoform SV13).
FT                                /FTId=VSP_008287.
FT   VAR_SEQ     240    253       GEARPAPAQKPAQL -> V (in isoform SV1,
FT                                isoform SV2, isoform SV3 and isoform
FT                                SV13).
FT                                /FTId=VSP_008288.
FT   VAR_SEQ     384    415       SALTEGDYVPDSPALLPIELKQELPKYLPALQ -> MKNEK
FT                                MKTTSWLFQSHGSTEIPGRVKKQRKKW (in isoform
FT                                SV7).
FT                                /FTId=VSP_008289.
FT   VAR_SEQ     564    597       GDFGLAREYGSPLKAYTPVVVTQWYRAPELLLGA -> SPP
FT                                PSGPSQGDPPGPTHSRPSVVAGG (in isoform
FT                                SV13).
FT                                /FTId=VSP_008290.
FT   VAR_SEQ     598    780       Missing (in isoform SV13).
FT                                /FTId=VSP_008291.
FT   VAR_SEQ     614    655       GELLTQKPLFPGNSEIDQINKVFKELGTPSEKIWPGYSELP
FT                                V -> MGKTEEKGNGKGAFQERKGPLGAVRKEAGAGAQDAG
FT                                AAEGAA (in isoform SV12).
FT                                /FTId=VSP_008292.
FT   VARIANT      57     57       C -> R (in dbSNP:rs17424353).
FT                                /FTId=VAR_060152.
FT   VARIANT      92     92       S -> P (in dbSNP:rs7531938).
FT                                /FTId=VAR_062200.
FT   VARIANT      93     93       R -> W (in dbSNP:rs1059831).
FT                                /FTId=VAR_031716.
FT   VARIANT     399    399       L -> S (in dbSNP:rs1059828).
FT                                /FTId=VAR_031717.
FT   VARIANT     655    655       V -> A (in dbSNP:rs1059811).
FT                                /FTId=VAR_060153.
FT   CONFLICT    109    109       Missing (in Ref. 1; AAA19594/AAA19595).
FT   CONFLICT    246    246       P -> R (in Ref. 2; AAC72087).
FT   CONFLICT    421    421       E -> D (in Ref. 1; AAA19585/AAA19594/
FT                                AAA19595).
FT   CONFLICT    460    460       K -> N (in Ref. 1; AAA19585/AAA19594/
FT                                AAA19595).
FT   CONFLICT    663    663       E -> R (in Ref. 1; AAA19585/AAA19594/
FT                                AAA19595).
FT   CONFLICT    679    679       D -> E (in Ref. 1; AAA19585/AAA19594/
FT                                AAA19595).
SQ   SEQUENCE   780 AA;  90974 MW;  CC6794E04029B7D6 CRC64;
     MGDEKDSWKV KTLDEILQEK KRRKEQEEKA EIKRLKNSDD RDSKRDSLEE GELRDHCMEI
     TIRNSPYRRE DSMEDRGEED DSLAIKPPQQ MSRKEKVHHR KDEKRKEKWK HARVKEREHE
     RRKRHREEQD KARREWERQK RREMAREHSR RERDRLEQLE RKRERERKMR EQQKEQREQK
     ERERRAEERR KEREARREVS AHHRTMREDY SDKVKASHWS RSPPRPPRER FELGDGRKPG
     EARPAPAQKP AQLKEEKMEE RDLLSDLQDI SDSERKTSSA ESSSAESGSG SEEEEEEEEE
     EEEEGSTSEE SEEEEEEEEE ETGSNSEEAS EQSAEEVSEE EMSEDEEREN ENHLLVVPES
     RFDRDSGESE EAEEEVGEGT PQSSALTEGD YVPDSPALLP IELKQELPKY LPALQGCRSV
     EEFQCLNRIE EGTYGVVYRA KDKKTDEIVA LKRLKMEKEK EGFPITSLRE INTILKAQHP
     NIVTVREIVV GSNMDKIYIV MNYVEHDLKS LMETMKQPFL PGEVKTLMIQ LLRGVKHLHD
     NWILHRDLKT SNLLLSHAGI LKVGDFGLAR EYGSPLKAYT PVVVTQWYRA PELLLGAKEY
     STAVDMWSVG CIFGELLTQK PLFPGNSEID QINKVFKELG TPSEKIWPGY SELPVVKKMT
     FSEHPYNNLR KRFGALLSDQ GFDLMNKFLT YFPGRRISAE DGLKHEYFRE TPLPIDPSMF
     PTWPAKSEQQ RVKRGTSPRP PEGGLGYSQL GDDDLKETGF HLTTTNQGAS AAGPGFSLKF
//
